Early research (Phase 1)Study completedNCT02173652
What this trial is testing
Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers
Who this might be right for
Healthy
Boehringer Ingelheim 16